Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valder R Arruda

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2007
The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII geneLingxia Chen, Fuxiang Zhu, Juan Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Blood|March 26, 2010
Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia BValder R Arruda, Hansell H Stedman, Virginia Haurigot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2008
Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transferJeannette Bennicelli, John Fraser Wright, Andras Komaromy, et al.
Blood|January 8, 2003
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia BCatherine S Manno, Amy J Chew, Sylvia Hutchison, et al.
Nature Medicine|February 14, 2006
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune responseCatherine S Manno, Glenn F Pierce, Valder R Arruda, et al.
The New England Journal of Medicine|December 7, 2017
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX VariantLindsey A George, Spencer K Sullivan, Adam Giermasz, et al.
The New England Journal of Medicine|April 29, 2008
Safety and efficacy of gene transfer for Leber's congenital amaurosisAlbert M Maguire, Francesca Simonelli, Eric A Pierce, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2007
The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII geneLingxia Chen, Fuxiang Zhu, Juan Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Blood|March 26, 2010
Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia BValder R Arruda, Hansell H Stedman, Virginia Haurigot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2008
Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transferJeannette Bennicelli, John Fraser Wright, Andras Komaromy, et al.
Blood|January 8, 2003
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia BCatherine S Manno, Amy J Chew, Sylvia Hutchison, et al.
Nature Medicine|February 14, 2006
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune responseCatherine S Manno, Glenn F Pierce, Valder R Arruda, et al.
The New England Journal of Medicine|December 7, 2017
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX VariantLindsey A George, Spencer K Sullivan, Adam Giermasz, et al.
The New England Journal of Medicine|April 29, 2008
Safety and efficacy of gene transfer for Leber's congenital amaurosisAlbert M Maguire, Francesca Simonelli, Eric A Pierce, et al.
Pageof 9